Exact Mass: 459.2005

Exact Mass Matches: 459.2005

Found 138 metabolites which its exact mass value is equals to given mass value 459.2005, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Apixaban

1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridine-3-carboxamide

C25H25N5O4 (459.1906)


B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AF - Direct factor xa inhibitors C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173067 - Direct Factor Xa Inhibitor C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C180619 - Direct Oral Anticoagulant D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

2-[(1S,2S,4R)-2-Hydroxy-7,7-dimethyl-1-(spiro[indene-1,4'-piperidine]-1'-ylsulfonylmethyl)-2-bicyclo[2.2.1]heptanyl]acetic acid

2-[(1S,2S,4R)-2-Hydroxy-7,7-dimethyl-1-(spiro[indene-1,4-piperidine]-1-ylsulphonylmethyl)-2-bicyclo[2.2.1]heptanyl]acetic acid

C25H33NO5S (459.2079)


   
   
   

15-Dimethyl-2-epi-fumiquinazoline A

15-Dimethyl-2-epi-fumiquinazoline A

C25H25N5O4 (459.1906)


   

Apixaban

Apixaban

C25H25N5O4 (459.1906)


B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AF - Direct factor xa inhibitors C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173067 - Direct Factor Xa Inhibitor C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C180619 - Direct Oral Anticoagulant D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Norneosildenafil

Norneosildenafil

C22H29N5O4S (459.194)


   

Pseudo Vardenafil

Pseudo Vardenafil

C22H29N5O4S (459.194)


   

rel-(5aR,6R,12S,14aR)-12-[(1R)-1,2-dihydroxy-2-methylpropyl]-1,2,3,5a,6,11,12,14a-octahydro-5a-hydroxy-6,9-dimethoxy-5H,14H-pyrrolo[1,2:4,5]pyrazino[1,2:1,6]pyrido[3,4-b]indole-5,14-dione|rel-(8S,19S)-19,20-dihydro-9,19,20-trihydroxy-8-methoxy-9-epi-fumitremorgin C

rel-(5aR,6R,12S,14aR)-12-[(1R)-1,2-dihydroxy-2-methylpropyl]-1,2,3,5a,6,11,12,14a-octahydro-5a-hydroxy-6,9-dimethoxy-5H,14H-pyrrolo[1,2:4,5]pyrazino[1,2:1,6]pyrido[3,4-b]indole-5,14-dione|rel-(8S,19S)-19,20-dihydro-9,19,20-trihydroxy-8-methoxy-9-epi-fumitremorgin C

C23H29N3O7 (459.2005)


   

Ala Asn Gln Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-4-carbamoylbutanamido]-4-carbamoylbutanoic acid

C17H29N7O8 (459.2078)


   

Ala Gln Asn Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-3-carbamoylpropanamido]-4-carbamoylbutanoic acid

C17H29N7O8 (459.2078)


   

Ala Gln Gln Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-4-carbamoylbutanamido]-3-carbamoylpropanoic acid

C17H29N7O8 (459.2078)


   

Asp Pro Gln Thr

(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]-3-hydroxybutanoic acid

C18H29N5O9 (459.1965)


   

Asp Pro Thr Gln

(2S)-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]-4-carbamoylbutanoic acid

C18H29N5O9 (459.1965)


   

Asp Gln Pro Thr

(3S)-3-amino-3-{[(2S)-4-carbamoyl-1-[(2S)-2-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamoyl}propanoic acid

C18H29N5O9 (459.1965)


   

Asp Gln Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carbamoylbutanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O9 (459.1965)


   

Asp Thr Pro Gln

(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C18H29N5O9 (459.1965)


   

Asp Thr Gln Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxybutanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O9 (459.1965)


   

Glu Asn Pro Thr

(4S)-4-amino-4-{[(2S)-3-carbamoyl-1-[(2S)-2-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}pyrrolidin-1-yl]-1-oxopropan-2-yl]carbamoyl}butanoic acid

C18H29N5O9 (459.1965)


   

Glu Asn Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carbamoylpropanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O9 (459.1965)


   

Glu Pro Asn Thr

(4S)-4-amino-5-[(2S)-2-{[(1S)-2-carbamoyl-1-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}ethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C18H29N5O9 (459.1965)


   

Glu Pro Gln Ser

(4S)-4-amino-5-[(2S)-2-{[(1S)-3-carbamoyl-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C18H29N5O9 (459.1965)


   

Glu Pro Ser Gln

(4S)-4-amino-5-[(2S)-2-{[(1S)-1-{[(1S)-3-carbamoyl-1-carboxypropyl]carbamoyl}-2-hydroxyethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C18H29N5O9 (459.1965)


   

Glu Pro Thr Asn

(4S)-4-amino-5-[(2S)-2-{[(1S,2R)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-hydroxypropyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C18H29N5O9 (459.1965)


   

Glu Gln Pro Ser

(4S)-4-amino-4-{[(2S)-4-carbamoyl-1-[(2S)-2-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamoyl}butanoic acid

C18H29N5O9 (459.1965)


   

Glu Gln Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-carbamoylbutanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O9 (459.1965)


   

Glu Ser Pro Gln

(4S)-4-amino-4-{[(2S)-1-[(2S)-2-{[(1S)-3-carbamoyl-1-carboxypropyl]carbamoyl}pyrrolidin-1-yl]-3-hydroxy-1-oxopropan-2-yl]carbamoyl}butanoic acid

C18H29N5O9 (459.1965)


   

Glu Ser Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-hydroxypropanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O9 (459.1965)


   

Glu Thr Asn Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-carboxybutanamido]-3-hydroxybutanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O9 (459.1965)


   

Glu Thr Pro Asn

(4S)-4-amino-4-{[(2S,3R)-1-[(2S)-2-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]carbamoyl}butanoic acid

C18H29N5O9 (459.1965)


   

Gly Gln Gln Gln

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-4-carbamoylbutanamido]-4-carbamoylbutanoic acid

C17H29N7O8 (459.2078)


   

Asn Ala Gln Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-4-carbamoylbutanamido]-4-carbamoylbutanoic acid

C17H29N7O8 (459.2078)


   

Asn Glu Pro Thr

(4S)-4-[(2S)-2-amino-3-carbamoylpropanamido]-5-[(2S)-2-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C18H29N5O9 (459.1965)


   

Asn Glu Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carboxybutanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O9 (459.1965)


   

Asn Asn Asn Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-methylbutanoic acid

C17H29N7O8 (459.2078)


   

Asn Asn Val Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-methylbutanamido]-3-carbamoylpropanoic acid

C17H29N7O8 (459.2078)


   

Asn Pro Glu Thr

(4S)-4-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-4-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}butanoic acid

C18H29N5O9 (459.1965)


   

Asn Pro Thr Glu

(2S)-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]pentanedioic acid

C18H29N5O9 (459.1965)


   

Asn Gln Ala Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carbamoylbutanamido]propanamido]-4-carbamoylbutanoic acid

C17H29N7O8 (459.2078)


   

Asn Gln Gln Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carbamoylbutanamido]-4-carbamoylbutanamido]propanoic acid

C17H29N7O8 (459.2078)


   

Asn Thr Glu Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O9 (459.1965)


   

Asn Thr Pro Glu

(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C18H29N5O9 (459.1965)


   

Asn Val Asn Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C17H29N7O8 (459.2078)


   

Pro Asp Gln Thr

(2S,3R)-2-[(2S)-4-carbamoyl-2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]-3-hydroxybutanoic acid

C18H29N5O9 (459.1965)


   

Pro Asp Thr Gln

(2S)-4-carbamoyl-2-[(2S,3R)-2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-hydroxybutanamido]butanoic acid

C18H29N5O9 (459.1965)


   

Pro Glu Asn Thr

(4S)-4-{[(1S)-2-carbamoyl-1-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}ethyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C18H29N5O9 (459.1965)


   

Pro Glu Gln Ser

(4S)-4-{[(1S)-3-carbamoyl-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C18H29N5O9 (459.1965)


   

Pro Glu Ser Gln

(4S)-4-{[(1S)-1-{[(1S)-3-carbamoyl-1-carboxypropyl]carbamoyl}-2-hydroxyethyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C18H29N5O9 (459.1965)


   

Pro Glu Thr Asn

(4S)-4-{[(1S,2R)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-hydroxypropyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C18H29N5O9 (459.1965)


   

Pro Asn Glu Thr

(4S)-4-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-4-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}butanoic acid

C18H29N5O9 (459.1965)


   

Pro Asn Thr Glu

(2S)-2-[(2S,3R)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-hydroxybutanamido]pentanedioic acid

C18H29N5O9 (459.1965)


   

Pro Gln Asp Thr

(2S,3R)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-carboxypropanamido]-3-hydroxybutanoic acid

C18H29N5O9 (459.1965)


   

Pro Gln Glu Ser

(4S)-4-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-4-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}butanoic acid

C18H29N5O9 (459.1965)


   

Pro Gln Ser Glu

(2S)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-hydroxypropanamido]pentanedioic acid

C18H29N5O9 (459.1965)


   

Pro Gln Thr Asp

(2S)-2-[(2S,3R)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-hydroxybutanamido]butanedioic acid

C18H29N5O9 (459.1965)


   

Pro Ser Glu Gln

(4S)-4-{[(1S)-3-carbamoyl-1-carboxypropyl]carbamoyl}-4-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanoic acid

C18H29N5O9 (459.1965)


   

Pro Ser Gln Glu

(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]pentanedioic acid

C18H29N5O9 (459.1965)


   

Pro Thr Asp Gln

(2S)-4-carbamoyl-2-[(2S)-3-carboxy-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]butanoic acid

C18H29N5O9 (459.1965)


   

Pro Thr Glu Asn

(4S)-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-4-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanoic acid

C18H29N5O9 (459.1965)


   

Pro Thr Asn Glu

(2S)-2-[(2S)-3-carbamoyl-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]pentanedioic acid

C18H29N5O9 (459.1965)


   

Pro Thr Gln Asp

(2S)-2-[(2S)-4-carbamoyl-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanamido]butanedioic acid

C18H29N5O9 (459.1965)


   

Gln Ala Asn Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]-3-carbamoylpropanamido]-4-carbamoylbutanoic acid

C17H29N7O8 (459.2078)


   

Gln Ala Gln Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]-4-carbamoylbutanamido]-3-carbamoylpropanoic acid

C17H29N7O8 (459.2078)


   

Gln Asp Pro Thr

(3S)-3-[(2S)-2-amino-4-carbamoylbutanamido]-4-[(2S)-2-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C18H29N5O9 (459.1965)


   

Gln Asp Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carboxypropanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O9 (459.1965)


   

Gln Glu Pro Ser

(4S)-4-[(2S)-2-amino-4-carbamoylbutanamido]-5-[(2S)-2-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C18H29N5O9 (459.1965)


   

Gln Glu Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-carboxybutanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O9 (459.1965)


   

Gln Gly Gln Gln

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-4-carbamoylbutanamido]-4-carbamoylbutanoic acid

C17H29N7O8 (459.2078)


   

Gln Asn Ala Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carbamoylpropanamido]propanamido]-4-carbamoylbutanoic acid

C17H29N7O8 (459.2078)


   

Gln Asn Gln Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carbamoylpropanamido]-4-carbamoylbutanamido]propanoic acid

C17H29N7O8 (459.2078)


   

Gln Pro Asp Thr

(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-carboxypropanamido]-3-hydroxybutanoic acid

C18H29N5O9 (459.1965)


   

Gln Pro Glu Ser

(4S)-4-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-4-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}butanoic acid

C18H29N5O9 (459.1965)


   

Gln Pro Ser Glu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]pentanedioic acid

C18H29N5O9 (459.1965)


   

Gln Pro Thr Asp

(2S)-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]butanedioic acid

C18H29N5O9 (459.1965)


   

Gln Gln Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-carbamoylbutanamido]propanamido]-3-carbamoylpropanoic acid

C17H29N7O8 (459.2078)


   

Gln Gln Gly Gln

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-carbamoylbutanamido]acetamido}-4-carbamoylbutanoic acid

C17H29N7O8 (459.2078)


   

Gln Gln Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-carbamoylbutanamido]-3-carbamoylpropanamido]propanoic acid

C17H29N7O8 (459.2078)


   

Gln Gln Gln Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-carbamoylbutanamido]-4-carbamoylbutanamido]acetic acid

C17H29N7O8 (459.2078)


   

Gln Ser Glu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O9 (459.1965)


   

Gln Ser Pro Glu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C18H29N5O9 (459.1965)


   

Gln Thr Asp Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxybutanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O9 (459.1965)


   

Gln Thr Pro Asp

(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C18H29N5O9 (459.1965)


   

Ser Glu Pro Gln

(4S)-4-[(2S)-2-amino-3-hydroxypropanamido]-5-[(2S)-2-{[(1S)-3-carbamoyl-1-carboxypropyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C18H29N5O9 (459.1965)


   

Ser Glu Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carboxybutanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O9 (459.1965)


   

Ser Pro Glu Gln

(4S)-4-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-4-{[(1S)-3-carbamoyl-1-carboxypropyl]carbamoyl}butanoic acid

C18H29N5O9 (459.1965)


   

Ser Pro Gln Glu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]pentanedioic acid

C18H29N5O9 (459.1965)


   

Ser Gln Glu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O9 (459.1965)


   

Ser Gln Pro Glu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C18H29N5O9 (459.1965)


   

Thr Asp Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C18H29N5O9 (459.1965)


   

Thr Asp Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carboxypropanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O9 (459.1965)


   

Thr Glu Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carboxybutanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O9 (459.1965)


   

Thr Glu Pro Asn

(4S)-4-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-[(2S)-2-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C18H29N5O9 (459.1965)


   

Thr Asn Glu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O9 (459.1965)


   

Thr Asn Pro Glu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C18H29N5O9 (459.1965)


   

Thr Pro Asp Gln

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-carboxypropanamido]-4-carbamoylbutanoic acid

C18H29N5O9 (459.1965)


   

Thr Pro Glu Asn

(4S)-4-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}butanoic acid

C18H29N5O9 (459.1965)


   

Thr Pro Asn Glu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]pentanedioic acid

C18H29N5O9 (459.1965)


   

Thr Pro Gln Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]butanedioic acid

C18H29N5O9 (459.1965)


   

Thr Gln Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carbamoylbutanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O9 (459.1965)


   

Thr Gln Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C18H29N5O9 (459.1965)


   

Val Asn Asn Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C17H29N7O8 (459.2078)


   

2-(2-ethoxy-5-piperidin-1-ylsulfonylphenyl)-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazin-4-one

2-(2-ethoxy-5-piperidin-1-ylsulfonylphenyl)-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazin-4-one

C22H29N5O4S (459.194)


   

(3S,4S)-TERT-BUTYL 3-ETHOXY-4-(2-(3-(TRIFLUOROMETHYL)BENZAMIDO)ACETAMIDO)PYRROLIDINE-1-CARBOXYLATE

(3S,4S)-TERT-BUTYL 3-ETHOXY-4-(2-(3-(TRIFLUOROMETHYL)BENZAMIDO)ACETAMIDO)PYRROLIDINE-1-CARBOXYLATE

C21H28F3N3O5 (459.1981)


   

Fluazacort

Fluazacort

C25H30FNO6 (459.2057)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid

   

Fmoc-Tyr-OtBu

Fmoc-Tyr-OtBu

C28H29NO5 (459.2046)


   

3-N-FMOC-AMINO-3-(2-T-BUTOXYPHENYL)PROPIONIC ACID

3-N-FMOC-AMINO-3-(2-T-BUTOXYPHENYL)PROPIONIC ACID

C28H29NO5 (459.2046)


   

3-N-FMOC-AMINO-3-(3-T-BUTOXYPHENYL)PROPIONIC ACID

3-N-FMOC-AMINO-3-(3-T-BUTOXYPHENYL)PROPIONIC ACID

C28H29NO5 (459.2046)


   

Fmoc-Tyr(tBu)-OH

Fmoc-Tyr(tBu)-OH

C28H29NO5 (459.2046)


   

Fmoc-D-Tyr(tBu)-OH

Fmoc-D-Tyr(tBu)-OH

C28H29NO5 (459.2046)


   

15,15-dimethyl-2-epi-fumiquinazoline A

15,15-dimethyl-2-epi-fumiquinazoline A

C25H25N5O4 (459.1906)


   

1-[(4-fluorophenyl)methyl]-N-[4-(4-methyl-1-piperazinyl)phenyl]-2-oxo-3H-benzimidazole-5-carboxamide

1-[(4-fluorophenyl)methyl]-N-[4-(4-methyl-1-piperazinyl)phenyl]-2-oxo-3H-benzimidazole-5-carboxamide

C26H26FN5O2 (459.207)


   

Prednisolone 21-hemisuccinate

Prednisolone 21-hemisuccinate

C25H31O8- (459.2019)


   

(6R,7R,8R)-N-(3-fluorophenyl)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7R,8R)-N-(3-fluorophenyl)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C27H26FN3O3 (459.1958)


   

1-(2,5-difluorophenyl)-3-[(2R,3S,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]urea

1-(2,5-difluorophenyl)-3-[(2R,3S,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]urea

C24H27F2N3O4 (459.197)


   

1-(2,5-difluorophenyl)-3-[(2S,3R,6S)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]urea

1-(2,5-difluorophenyl)-3-[(2S,3R,6S)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]urea

C24H27F2N3O4 (459.197)


   

1-(2,5-difluorophenyl)-3-[(2S,3R,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea

1-(2,5-difluorophenyl)-3-[(2S,3R,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea

C24H27F2N3O4 (459.197)


   

1-(2,5-difluorophenyl)-3-[(2S,3S,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea

1-(2,5-difluorophenyl)-3-[(2S,3S,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea

C24H27F2N3O4 (459.197)


   

1-(2,5-difluorophenyl)-3-[(2R,3S,6S)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea

1-(2,5-difluorophenyl)-3-[(2R,3S,6S)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea

C24H27F2N3O4 (459.197)


   

1-(2,5-difluorophenyl)-3-[(2R,3R,6S)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea

1-(2,5-difluorophenyl)-3-[(2R,3R,6S)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea

C24H27F2N3O4 (459.197)


   

(2R,3R,3aS,9bS)-2-[3,4-dihydro-1H-isoquinolin-2-yl(oxo)methyl]-7-(2-fluorophenyl)-3-(hydroxymethyl)-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizin-6-one

(2R,3R,3aS,9bS)-2-[3,4-dihydro-1H-isoquinolin-2-yl(oxo)methyl]-7-(2-fluorophenyl)-3-(hydroxymethyl)-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizin-6-one

C27H26FN3O3 (459.1958)


   

[(1R)-7-methoxy-2-methyl-1-[(1-methyl-4-imidazolyl)sulfonyl]-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol

[(1R)-7-methoxy-2-methyl-1-[(1-methyl-4-imidazolyl)sulfonyl]-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol

C22H29N5O4S (459.194)


   

[(1S)-7-methoxy-2-methyl-1-[(1-methyl-4-imidazolyl)sulfonyl]-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol

[(1S)-7-methoxy-2-methyl-1-[(1-methyl-4-imidazolyl)sulfonyl]-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol

C22H29N5O4S (459.194)


   

(6S,7S,8R)-N-(3-fluorophenyl)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6S,7S,8R)-N-(3-fluorophenyl)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C27H26FN3O3 (459.1958)


   

1-(2,5-difluorophenyl)-3-[(2S,3S,6S)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea

1-(2,5-difluorophenyl)-3-[(2S,3S,6S)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea

C24H27F2N3O4 (459.197)


   

1-(2,5-difluorophenyl)-3-[(2R,3R,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea

1-(2,5-difluorophenyl)-3-[(2R,3R,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea

C24H27F2N3O4 (459.197)


   

(2S,3S,3aR,9bR)-2-[3,4-dihydro-1H-isoquinolin-2-yl(oxo)methyl]-7-(2-fluorophenyl)-3-(hydroxymethyl)-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizin-6-one

(2S,3S,3aR,9bR)-2-[3,4-dihydro-1H-isoquinolin-2-yl(oxo)methyl]-7-(2-fluorophenyl)-3-(hydroxymethyl)-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizin-6-one

C27H26FN3O3 (459.1958)


   

(6S,7S,8S)-N-(3-fluorophenyl)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6S,7S,8S)-N-(3-fluorophenyl)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C27H26FN3O3 (459.1958)


   

(6R,7R,8S)-N-(3-fluorophenyl)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7R,8S)-N-(3-fluorophenyl)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C27H26FN3O3 (459.1958)


   
   
   

CZ415

CZ415

C22H29N5O4S (459.194)


CZ415 is a potent and highly selective mTOR inhibitor with a pIC50 of 8.07. CZ415 inhibits mTORC1 and mTORC2 protein complex. CZ415 is a potent and highly selective mTOR inhibitor with a pIC50 of 8.07. CZ415 inhibits mTORC1 and mTORC2 protein complex.

   

IDH1 Inhibitor 7

IDH1 Inhibitor 7

C22H24F3N7O (459.1994)


IDH1 Inhibitor 7 (Compound 88) is an IDH1 inhibitor with an IC50 of less than 100 nM[1].

   

(1r,2r,12s,15r)-12-[(1r)-1,2-dihydroxy-2-methylpropyl]-1-hydroxy-2,7-dimethoxy-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione

(1r,2r,12s,15r)-12-[(1r)-1,2-dihydroxy-2-methylpropyl]-1-hydroxy-2,7-dimethoxy-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione

C23H29N3O7 (459.2005)


   

{[(2r,3r,4s,5r,6r)-5-(2-amino-n-methylacetamido)-4-hydroxy-6-{[(7r)-7-hydroxy-5-methyl-4-oxo-3h,3ah,6h,7h,7ah-imidazo[4,5-c]pyridin-2-yl]amino}-2-(hydroxymethyl)oxan-3-yl]oxy}methanimidic acid

{[(2r,3r,4s,5r,6r)-5-(2-amino-n-methylacetamido)-4-hydroxy-6-{[(7r)-7-hydroxy-5-methyl-4-oxo-3h,3ah,6h,7h,7ah-imidazo[4,5-c]pyridin-2-yl]amino}-2-(hydroxymethyl)oxan-3-yl]oxy}methanimidic acid

C17H29N7O8 (459.2078)


   

{[(2r,3r,4s,5r,6r)-6-{[(3as,7r,7as)-7-hydroxy-5-methyl-4-oxo-3h,3ah,6h,7h,7ah-imidazo[4,5-c]pyridin-2-yl]amino}-5-(2-amino-n-methylacetamido)-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}methanimidic acid

{[(2r,3r,4s,5r,6r)-6-{[(3as,7r,7as)-7-hydroxy-5-methyl-4-oxo-3h,3ah,6h,7h,7ah-imidazo[4,5-c]pyridin-2-yl]amino}-5-(2-amino-n-methylacetamido)-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}methanimidic acid

C17H29N7O8 (459.2078)


   

{[(2s,3r,4r,5r,6r)-6-{[(3as,7r,7as)-7-hydroxy-5-methyl-4-oxo-3h,3ah,6h,7h,7ah-imidazo[4,5-c]pyridin-2-yl]amino}-5-(2-amino-n-methylacetamido)-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}methanimidic acid

{[(2s,3r,4r,5r,6r)-6-{[(3as,7r,7as)-7-hydroxy-5-methyl-4-oxo-3h,3ah,6h,7h,7ah-imidazo[4,5-c]pyridin-2-yl]amino}-5-(2-amino-n-methylacetamido)-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}methanimidic acid

C17H29N7O8 (459.2078)


   

{[5-(2-amino-n-methylacetamido)-4-hydroxy-6-({7-hydroxy-5-methyl-4-oxo-3h,3ah,6h,7h,7ah-imidazo[4,5-c]pyridin-2-yl}amino)-2-(hydroxymethyl)oxan-3-yl]oxy}methanimidic acid

{[5-(2-amino-n-methylacetamido)-4-hydroxy-6-({7-hydroxy-5-methyl-4-oxo-3h,3ah,6h,7h,7ah-imidazo[4,5-c]pyridin-2-yl}amino)-2-(hydroxymethyl)oxan-3-yl]oxy}methanimidic acid

C17H29N7O8 (459.2078)


   

12-(1,2-dihydroxy-2-methylpropyl)-1-hydroxy-2,7-dimethoxy-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione

12-(1,2-dihydroxy-2-methylpropyl)-1-hydroxy-2,7-dimethoxy-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione

C23H29N3O7 (459.2005)